Management Team

R. Stephen Beatty is our President and Chief Executive Officer and has served on the Board of Directors since May 1999. Prior to joining the Company, Mr. Beatty established and operated Beatty Finance, Inc., a private financial services company serving the legal profession. Prior to founding Beatty Finance, Inc., Mr. Beatty worked with BellSouth where he managed one of BellSouth’s corporate re-engineering teams, directed the development of enterprise software for BellSouth’s marketing division and was a member of BellSouth’s “Future Thinkers”, an in-house corporate think tank. Mr. Beatty obtained his Bachelor of Science in Mathematics with a minor in Economics from the University of South Alabama in 1975. He obtained his Masters in Business Administration from the University of New Orleans in 1997.

Timothy Falla, Ph.D. is our Vice President and Chief Scientific Officer. Dr. Falla joined the Company as Chief Scientific Officer in June 2001 and was appointed as a Vice President in December 2001. He is responsible for developing the Company’s science and technology and for it’s application to clinical and non-clinical product candidates. Prior to joining the Company, Dr. Falla was employed by IntraBiotics Pharmaceuticals, Inc., a biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases. As Principal Scientist he led a multi-disciplinary scientific research team focused on antibacterial drug discovery and development. Prior to his tenure with IntraBiotics, Dr. Falla held research associate position at the University of British Columbia and The Antimicrobial Research Centre at the University of Leeds. Dr. Falla received his Bachelor of Science degree in Applied Biology from the University of Wales in 1989, and obtained his Ph.D. in the Molecular Biology of Infectious Disease from Oxford University and The University of Wales in 1993.

Robin Carmichael is our Vice President of Marketing and Business Development. Ms. Carmichael joined the Company in October 2007. Prior to joining Helix, Ms. Carmichael most recently served as Chief Operating Officer of DERMAdoctor, Inc., a prestige skin company specializing in over-the-counter drugs and cosmeceuticals. She was Vice President of Marketing with ProCyte Corporation and Photomedex, Inc. following its acquisition of ProCyte in 2005, where she held a number of product marketing positions prior to her appointment as Vice President of Marketing in 1998. During her tenure at ProCyte, she developed and launched seven major product lines and created several new brands. In addition, she established the international distribution business and was actively involved with the various licensing partners. Ms. Carmichael has over 25 years of sales and marketing experience having held a number of regional and national sales positions in the life science and medical device companies, including Baxter Healthcare. She holds a Bachelor of Science in Nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management. She is a recognized speaker and author on numerous topics, including peptides, cosmetic surgery and skin care and is a member of Cosmetic Executive Women.